Skip to main content
Year archive

Diasorin — 2021 filings

All 106 regulatory filings released by Diasorin (DIA) in 2021, sourced directly from the official regulator.

106 Filings
2021 Period
2021 filings (106)
Filing Released Lang
DiaSorin S.p.A. - 2022 Annual Calendar of Corporate Events
Report Publication Announcement
2021-12-21 English
DiaSorin S.p.A. - Calendario Annuale Eventi Societari 2022
Report Publication Announcement
2021-12-21 Italian
DiaSorin Investor Day 2021 presentation
Investor Presentation
2021-12-17 English
Piano Industriale DiaSorin 2022-2025: Specialist3
Management Reports
2021-12-16 Italian
DiaSorin 2022-2025 Strategic Plan: Specialist3
Investor Presentation
2021-12-16 English
Communication on total amount of voting rights
Declaration of Voting Results & Voting Rights Announcements
2021-12-07 English
Comunicazione ammontare complessivo dei diritti di voto
Declaration of Voting Results & Voting Rights Announcements
2021-12-07 Italian
DiaSorin business momentum and the Luminex acquisition drive Revenues and Profitability up in the first 9 months of 2021
Earnings Release 9M 2021
2021-11-11 English
La crescita del business DiaSorin e l’acquisizione Luminex trainano l’aumento dei Ricavi e della Redditività nei primi 9 mesi del 2021
Earnings Release 9M 2021
2021-11-11 Italian
Report on the treasury shares buy-back plan of DiaSorin S.p.A. - Period 03/11/2021 - 04/11/2021
Transaction in Own Shares
2021-11-05 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 03/11/2021 - 04/11/2021
Transaction in Own Shares
2021-11-05 Italian
Comunicazione ammontare complessivo dei diritti di voto
Declaration of Voting Results & Voting Rights Announcements
2021-11-05 Italian
Communication on total amount of voting rights.
Declaration of Voting Results & Voting Rights Announcements
2021-11-05 English
CONCLUSION OF THE TREASURY SHARES BUY-BACK PLAN OF DIASORIN S.P.A.
Transaction in Own Shares
2021-11-02 English
CONCLUSIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE DIASORIN S.P.A.
Transaction in Own Shares
2021-11-02 Italian
REPORT ON THE TREASURY SHARES BUY-BACK PLAN OF DIASORIN S.P.A. - PERIOD 26/10/2021 - 02/11/2021
Transaction in Own Shares
2021-11-02 English
INFORMATIVA SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE DI DIASORIN S.P.A. - PERIODO 26/10/2021 - 02/11/2021
Transaction in Own Shares
2021-11-02 Italian
Extraordinary Shareholders' Meeting minutes October 4, 2021
AGM Information
2021-11-02 English
Verbale Assemblea Straordinaria degli Azionisti 4 ottobre 2021
Pre-Annual General Meeting Information
2021-11-02 Italian
ISSUANCE OF THE “PHYSICAL SETTLEMENT NOTICE”
Share Issue/Capital Change
2021-10-27 English
EMISSIONE DELLA “PHYSICAL SETTLEMENT NOTICE”
Capital/Financing Update
2021-10-27 Italian
By-laws (updated at October 4, 2021)
Regulatory Filings
2021-10-21 English
Statuto sociale (aggiornato al 4 ottobre 2021)
Governance Information
2021-10-21 Italian
PUBLICATION OF THE SUMMARY REPORT OF THE VOTES CAST
Declaration of Voting Results & Voting Rights Announcements
2021-10-07 English
PUBBLICAZIONE DEL RENDICONTO SINTETICO DELLE VOTAZIONI
Declaration of Voting Results & Voting Rights Announcements
2021-10-07 Italian
THE EXTRAORDINARY SHAREHOLDERS’ MEETING OF DIASORIN AUTHORIZES THE CONVERTIBILITY OF THE EQUITY-LINKED BOND AND THE SHARE CAPITAL INCREASE
AGM Information
2021-10-04 English
L’ASSEMBLEA STRAORDINARIA DEGLI AZIONISTI DI DIASORIN AUTORIZZA LA CONVERTIBILITÀ DEL PRESTITO OBBLIGAZIONARIO E L’AUMENTO DI CAPITALE
Share Issue/Capital Change
2021-10-04 Italian
Communication on total amount of voting rights
Declaration of Voting Results & Voting Rights Announcements
2021-09-24 English
Comunicazione ammontare complessivo diritti di voto.
Declaration of Voting Results & Voting Rights Announcements
2021-09-24 Italian
DiaSorin CE Marks its new Simplexa™ COVID-19 & Flu A/B Direct Assay
Regulatory Filings
2021-09-18 English
DiaSorin lancia il nuovo test Simplexa™ COVID-19 & Flu A/B Direct nei paesi che accettano la marcatura CE
Regulatory Filings
2021-09-18 Italian
PUBBLICAZIONE DELLA RELAZIONE ILLUSTRATIVA EX ART 125-TER TUF E DEL PARERE EX ART. 2441, CO. 5 E 6, C.C.
Report Publication Announcement
2021-09-10 Italian
Assemblea degli Azionisti 4 ottobre 2021 - Parere ex art 2441, co 5 e 6, c.c. e 158 TUF
Capital/Financing Update
2021-09-10 Italian
Shareholders' Meeting October 4, 2021 - Report and motion for resolution
Capital/Financing Update
2021-09-10 English
Assemblea degli Azionisti 4 ottobre 2021 - Relazione illustrativa e proposta di delibera
Share Issue/Capital Change
2021-09-10 Italian
Assemblea Straordinaria degli Azionisti del 4 ottobre 2021 - Modulo delega SPAFID (Rappresentante Designato)
Proxy Solicitation & Information Statement
2021-09-01 Italian
Assemblea Straordinaria degli Azionisti del 4 ottobre 2021 - Modulo delega SPAFID (art. 135-novies TUF)
Proxy Solicitation & Information Statement
2021-09-01 Italian
DiaSorin S.p.A. - Extraordinary Shareholders' Meeting October 4, 2021 - Notice
AGM Information
2021-09-01 Italian
DiaSorin S.p.A. - Assemblea Straordinaria degli Azionisti 4 ottobre 2021 - Avviso di convocazione
AGM Information
2021-09-01 Italian
Half-year financial report - June 30, 2021
Interim / Quarterly Report H1 2021
2021-08-06 English
Relazione Finanziaria Semestrale del Gruppo DiaSorin al 30 giugno 2021
Interim / Quarterly Report H1 2021
2021-08-04 Italian
START UP OF THE TREASURY SHARES BUY-BACK PLAN OF DIASORIN S.P.A.
Transaction in Own Shares
2021-07-30 English
AVVIO PROGRAMMA DI ACQUISTO AZIONI PROPRIE DIASORIN S.P.A.
Transaction in Own Shares
2021-07-30 Italian
DiaSorin: Revenues and Profitability continue upward momentum in the First Half of 2021, with Guidance raised following the acquisition of Luminex
Earnings Release H1 2021
2021-07-30 English
DiaSorin: fatturato e redditività in continua crescita nel 1° semestre 2021 ed incremento della guidance a seguito dell’acquisizione di Luminex
Interim / Quarterly Report H1 2021
2021-07-30 Italian
DiaSorin: Publication of Information Document under the provisions of the art. 71of the CONSOB Regulation n. 11971/1999
Report Publication Announcement
2021-07-23 English
Information Document pursuant to art. 71 of the Issuers' Regulation - Acquisition of Luminex Corporation
M&A Activity
2021-07-22 English
DiaSorin: Pubblicazione Documento Informativo ai sensi dell’art. 71 Regolamento CONSOB n. 11971/99
Report Publication Announcement
2021-07-22 Italian
Documento Informativo ex art. 71 Regolamento Emittenti - Operazione di acquisizione di Luminex Corporation
M&A Activity
2021-07-22 Italian
Communication on total amount of voting rights
Declaration of Voting Results & Voting Rights Announcements
2021-06-07 English
Comunicazione ammontare complessivo diritti di voto
Declaration of Voting Results & Voting Rights Announcements
2021-06-07 Italian
DiaSorin: lancio del nuovo test dell’antigene LIAISON® Quick Detect COVID Ag per la diagnosi del COVID-19
Regulatory Filings
2021-05-25 Italian
DiaSorin: launch of the LIAISON® Quick Detect COVID Ag assay, an antigen test to detect COVID-19 infection
Regulatory Filings
2021-05-25 English
DiaSorin lancia un nuovo test molecolare per l’identificazione rapida delle mutazioni associate alle varianti del SARS-CoV-2
Regulatory Filings
2021-05-21 Italian
DiaSorin Releases an Assay for Rapid Identification of Mutations Associated with Circulating Variants of SARS-CoV-2
Regulatory Filings
2021-05-21 English
DiaSorin’s LIAISON® SARS-CoV-2 TrimericS IgG test receives FDA Emergency Use Authorization for the U.S. market
Regulatory Filings
2021-05-20 English
DiaSorin riceve l’approvazione ad uso di emergenza dalla Food and Drug Administration per il test LIAISON® SARS-CoV-2 TrimericS IgG negli Stati Uniti
Regulatory Filings
2021-05-20 Italian
Notice availability Shareholders' Meeting minutes April 22, 2021
Report Publication Announcement
2021-05-18 English
Avviso disponibilita' verbale Assemblea degli Azionisti 22 aprile 2021
AGM Information
2021-05-18 Italian
By-Laws (updated at April 22, 2021)
Regulatory Filings
2021-05-18 English
Statuto sociale (aggiornato al 22 aprile 2021)
Governance Information
2021-05-18 Italian
Verbale Assemblea Straordinaria degli Azionisti 22 aprile 2021
Pre-Annual General Meeting Information
2021-05-18 Italian
Verbale Assemblea Ordinaria degli Azionisti 22 aprile 2021
AGM Information
2021-05-18 English
DiaSorin: significant growth in Revenues and Profitability in the first quarter 2021
Interim / Quarterly Report Q1 2021
2021-05-14 English
DiaSorin: Fatturato e Redditività in forte crescita nel 1° trimestre 2021
Interim / Quarterly Report Q1 2021
2021-05-14 Italian
DiaSorin colloca con successo il prestito obbligazionario senior unsecured equity-linked da euro 500 milioni con scadenza al 2028
Capital/Financing Update
2021-04-28 Italian
DiaSorin successfully prices its offer of € 500 million Senior Unsecured Equity-Linked Bonds due 2028
Capital/Financing Update
2021-04-28 English
DiaSorin announces its intention to offer € 500 million senior unsecured equity-linked bonds due 2028
Capital/Financing Update
2021-04-28 English
DiaSorin annuncia l’avvio del collocamento di un prestito obbligazionario senior unsecured equity-linked per Euro 500 milioni con scadenza al 2028
Capital/Financing Update
2021-04-28 Italian
DiaSorin - Shareholders' meeting April 22, 2021
AGM Information
2021-04-22 English
DiaSorin - Assemblea degli Azionisti 22 aprile 2021
AGM Information
2021-04-22 Italian
DiaSorin launches the LIAISON® IQ with a first test that detects IgG antibodies against SARS-COV-2
Regulatory Filings
2021-04-20 English
DiaSorin lancia il LIAISON® IQ insieme al primo test per l’identificazione degli anticorpi IgG contro il SARS-CoV-2
Regulatory Filings
2021-04-20 Italian
Annual Financial Report at December 31, 2020
Annual Report FY 2020
2021-04-19 English
Report on the remuneration policy and fees paid 2020
Remuneration Information
2021-04-14 English
Communication voting rights amount
Declaration of Voting Results & Voting Rights Announcements
2021-04-14 English
Comunicazione ammontare complessivo diritti di voto
Declaration of Voting Results & Voting Rights Announcements
2021-04-14 Italian
Presentation - DiaSorin to acquire Luminex Corporation
Investor Presentation
2021-04-12 English
DiaSorin S.p.A. - Informativa settimanale acquisto azioni proprie
Transaction in Own Shares
2021-04-12 Italian
DiaSorin S.p.A. - Weekly report treasury shares buy-back
Transaction in Own Shares
2021-04-12 English
DiaSorin: accordo per acquisire Luminex Corporation per un valore di USD 37,00 per ciascuna azione, per complessivi USD 1,8 Miliardi circa
M&A Activity
2021-04-11 Italian
DiaSorin to acquire Luminex Corporation for USD 37.00 per share or approximately USD 1.8 billion
M&A Activity
2021-04-11 English
DiaSorin S.p.A.-Start up buy-back plan
Transaction in Own Shares
2021-04-06 English
DiaSorin S.p.A.-Avvio programma acquisto azioni proprie
Transaction in Own Shares
2021-04-06 Italian
DiaSorin annuncia la collaborazione strategica con Lumos Diagnostics
Regulatory Filings
2021-04-06 Italian
DiaSorin announces its strategic collaboration with Lumos Diagnostics
Regulatory Filings
2021-04-06 English
Notice of availability Annual Report and related documentation
Report Publication Announcement
2021-03-31 English
Avviso disponibilita' Relazione Finanziaria Annuale e documenti correlati
Report Publication Announcement
2021-03-31 Italian
Relazione sulla politica in materia di remunerazione e sui compensi corrisposti (Esercizio 2020)
Remuneration Information
2021-03-31 Italian
Relazione Finanziaria Annuale al 31 dicembre 2020
Annual Report FY 2020
2021-03-31 Italian
DiaSorin: il test dell’antigene LIAISON® SARS-CoV-2 Ag per la diagnosi del COVID-19 ha ricevuto l’approvazione ad uso di emergenza negli Stati Uniti
Regulatory Filings
2021-03-29 Italian
DiaSorin has obtained FDA Emergency Use Authorization for its LIAISON® SARS-CoV-2 Ag for COVID-19 testing in the U.S.
Regulatory Filings
2021-03-29 English
DiaSorin S.p.A. - Notice of Shareholders' Meeting April 22, 2021
AGM Information
2021-03-19 Italian
DiaSorin S.p.A. - Assemblea degli Azionisti 22 aprile 2021 - Avviso di convocazione
AGM Information
2021-03-19 Italian
Assemblea degli Azionisti 22 aprile 2021 - Modulo delega SPAFID (Rappresentante Designato)
Proxy Solicitation & Information Statement
2021-03-19 Italian
Assemblea degli Azionisti 22 aprile 2021 - Modulo delega SPAFID (art. 135-novies TUF)
AGM Information
2021-03-19 Italian
Shareholders' Meeting April 22, 2021 - Reports and motions for resolutions
AGM Information
2021-03-19 English
Assemblea degli Azionisti 22 aprile 2021 - Relazioni illustrative e proposte di delibera
AGM Information
2021-03-19 Italian
DiaSorin S.p.A. - Dividend coupon date correction
Notice of Dividend Amount
2021-03-11 English
DiaSorin S.p.A. - Rettifica data stacco dividendo
Notice of Dividend Amount
2021-03-11 Italian
DiaSorin – Revenues, Profitability and Cash Flow Generation hit record highs in 2020
Earnings Release FY 2020
2021-03-11 English
DiaSorin – Ricavi, Redditività e Generazione di Cassa Record nel 2020
Earnings Release FY 2020
2021-03-11 Italian
DiaSorin S.p.A. - 2021 Annual Calendar of Corporate Events
Report Publication Announcement
2021-01-27 Italian
DiaSorin S.p.A. - Calendario Annuale Eventi Societari 2021
Regulatory Filings
2021-01-27 Italian
DiaSorin launches with CE mark the LIAISON SARS-CoV-2 TrimericS IgG test
Regulatory Filings
2021-01-11 English
DiaSorin lancia con marcatura CE il LIAISON® SARS-CoV-2 TrimericS IgG
Regulatory Filings
2021-01-11 Italian